Suk Bae Seo
Research Subjects
Suk Bae Seo has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Kuk Hui Son
Department of Thoracic and Cardiovascular Surgery, Gachon University Gil Medical Center, Gachon University, Incheon, South Korea
6 shared publications - Kyunghee Byun
Department of Anatomy & Cell Biology, College of Medicine, Gachon University, Incheon 21936, Republic of Korea
6 shared publications - Seyeon Oh
Functional Cellular Networks Laboratory, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon 21999, Republic of Korea
6 shared publications - Chang-Hun Huh
Department of Dermatology Seoul National University Bundang Hospital Seongnam Korea
4 shared publications - Hae Woong Lee
Louis Dermatology Clinic, Guri, Korea
4 shared publications - Hwa Jung Ryu
Department of Dermatology, Korea University Ansan Hospital, Ansan, Korea
4 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7904
Pulsed Electromagnetic Field Exposure Attenuates Ultraviolet B-Induced Dermal Collagen Loss in Association with A2A Adenosine Receptor Signaling
Ultraviolet (UV) exposure accelerates skin aging through wavelength-dependent effects. Ultraviolet A (UVA) penetrates relatively deeply into the dermis and promotes oxidative stress and extracellular-matrix remodeling, whereas ultraviolet B (UVB) is absorbed predominantly in the epidermis and produces direct DNA damage and inflammation; nevertheless, UVB can also alter dermal fibroblast matrix metabolism in experimental models. The present study specifically used UVB irradiation (peak wavelength, 306 nm) to examine inflammatory collagen loss. UVB-induced cellular injury activates the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, leading to caspase-1-dependent maturation of interleukin-1β (IL-1β), activation of nuclear factor-κB (NF-κB), and matrix metalloproteinase (MMP)-associated collagen degradation. Pulsed electromagnetic field (PEMF) stimulation is a non-optical biophysical modality that may modulate inflammatory and matrix responses. Here, we characterized the effects of PEMF exposure using Corefacial on UVB-induced dermal collagen loss in association with the A2A adenosine receptor (A2AAR)/cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway. In UVB-exposed fibroblasts, PEMF restored A2AAR and PKA protein levels, cAMP levels, and the pNLRP3/NLRP3 ratio, similar to the effects of the A2AAR agonist CGS-21680. PEMF also reduced apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), caspase-1 activation markers, IL-1β secretion, NF-κB nuclear translocation, and MMP2/MMP3/MMP9 expression and increased the levels of collagen I and collagen III. In the in vivo UVB model, PEMF similarly increased A2AAR and PKA protein levels, cAMP levels, and the pNLRP3/NLRP3 ratio, while attenuating IL-1β/NF-κB/MMP-associated responses and preserving dermal collagen. These findings are consistent with, but do not prove, involvement of A2AAR/cAMP/PKA-related signaling and inhibitory NLRP3 phosphorylation in the PEMF response. These results should be interpreted as evidence from a UVB-specific experimental model rather than a comprehensive model of solar photoaging.
- 4 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (17) , 7904
Open AccessPulsed Electromagnetic Field Exposure Attenuates Ultraviolet B-Induced Dermal Collagen Loss in Association with A2A Adenosine Receptor Signaling
Ultraviolet (UV) exposure accelerates skin aging through wavelength-dependent effects. Ultraviolet A (UVA) penetrates relatively deeply into the dermis and promotes oxidative stress and extracellular-matrix remodeling, whereas ultraviolet B (UVB) is absorbed predominantly in the epidermis and produces direct DNA damage and inflammation; nevertheless, UVB can also alter dermal fibroblast matrix metabolism in experimental models. The present study specifically used UVB irradiation (peak wavelength, 306 nm) to examine inflammatory collagen loss. UVB-induced cellular injury activates the NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome, leading to caspase-1-dependent maturation of interleukin-1β (IL-1β), activation of nuclear factor-κB (NF-κB), and matrix metalloproteinase (MMP)-associated collagen degradation. Pulsed electromagnetic field (PEMF) stimulation is a non-optical biophysical modality that may modulate inflammatory and matrix responses. Here, we characterized the effects of PEMF exposure using Corefacial on UVB-induced dermal collagen loss in association with the A2A adenosine receptor (A2AAR)/cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway. In UVB-exposed fibroblasts, PEMF restored A2AAR and PKA protein levels, cAMP levels, and the pNLRP3/NLRP3 ratio, similar to the effects of the A2AAR agonist CGS-21680. PEMF also reduced apoptosis-associated speck-like protein containing a caspase-recruitment domain (ASC), caspase-1 activation markers, IL-1β secretion, NF-κB nuclear translocation, and MMP2/MMP3/MMP9 expression and increased the levels of collagen I and collagen III. In the in vivo UVB model, PEMF similarly increased A2AAR and PKA protein levels, cAMP levels, and the pNLRP3/NLRP3 ratio, while attenuating IL-1β/NF-κB/MMP-associated responses and preserving dermal collagen. These findings are consistent with, but do not prove, involvement of A2AAR/cAMP/PKA-related signaling and inhibitory NLRP3 phosphorylation in the PEMF response. These results should be interpreted as evidence from a UVB-specific experimental model rather than a comprehensive model of solar photoaging.
- Open Access
- 19 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6425
Immunomodulatory Effects of Poly-D,L-Lactic Acid on LL-37-Driven Rosacea-like Inflammation via Suppression of mTORC1 Signaling
Rosacea is a chronic inflammatory skin disorder driven by dysregulated cathelicidin processing and excessive LL-37, which triggers a circuit involving Toll-like receptor 2 (TLR2)/kallikrein-5 (KLK5)-dependent amplification and downstream mechanistic target of rapamycin complex 1 (mTORC1), NF-κB, and NLR family pyrin domain containing 3 (NLRP3) inflammasome pathways. We hypothesized that poly-D,L-lactic acid (PDLLA) could attenuate this inflammatory cascade by inducing macrophage-derived interleukin (IL)-10. PDLLA increased IL-10 secretion from THP-1-derived macrophages in a dose-dependent manner. In LL-37-stimulated HaCaT keratinocytes, LL-37 decreased phosphorylated signal transducer and activator of transcription (pSTAT3)/STAT3, DNA damage-inducible transcript 4 (DDIT4), and phosphorylated AMP-activated protein kinase (pAMPK)/AMPK while increasing phosphorylated protein kinase B (pAKT)/AKT and mTORC1 activation; conditioned media from PDLLA-treated macrophages (CMPDLLA) restored pSTAT3/STAT3, DDIT4, and pAMPK/AMPK, reduced pAKT/AKT, and suppressed pmTOR/mTOR. CMPDLLA attenuated downstream inflammatory responses, including NF-κB nuclear translocation, VEGF production, and NLRP3-inflammasome-mediated IL-18 secretion. These findings were validated using an intradermal LL-37-injected mouse model. Compared with the normal control/saline group, LL-37/saline decreased IL-10, pSTAT3/STAT3, DDIT4, and pAMPK/AMPK while increasing pAKT/AKT, pmTOR/mTOR, pS6K/S6K, TLR2/KLK5/LL-37, NF-κB, VEGF, and NLRP3 inflammasome/IL-18 signaling; PDLLA partially restored the STAT3/DDIT4–AMPK regulatory pattern and suppressed these disease-associated signals. Consequently, PDLLA treatment led to a pronounced reduction in clinical lesion area. Overall, PDLLA may attenuate LL-37-driven cutaneous inflammation by promoting an IL-10-linked STAT3/DDIT4–AKT/AMPK program that suppresses mTORC1 and disrupts cathelicidin amplification, supporting its potential as an injectable immunomodulatory approach for rosacea-like skin inflammation.
- 19 July 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (14) , 6425
Open AccessImmunomodulatory Effects of Poly-D,L-Lactic Acid on LL-37-Driven Rosacea-like Inflammation via Suppression of mTORC1 Signaling
Rosacea is a chronic inflammatory skin disorder driven by dysregulated cathelicidin processing and excessive LL-37, which triggers a circuit involving Toll-like receptor 2 (TLR2)/kallikrein-5 (KLK5)-dependent amplification and downstream mechanistic target of rapamycin complex 1 (mTORC1), NF-κB, and NLR family pyrin domain containing 3 (NLRP3) inflammasome pathways. We hypothesized that poly-D,L-lactic acid (PDLLA) could attenuate this inflammatory cascade by inducing macrophage-derived interleukin (IL)-10. PDLLA increased IL-10 secretion from THP-1-derived macrophages in a dose-dependent manner. In LL-37-stimulated HaCaT keratinocytes, LL-37 decreased phosphorylated signal transducer and activator of transcription (pSTAT3)/STAT3, DNA damage-inducible transcript 4 (DDIT4), and phosphorylated AMP-activated protein kinase (pAMPK)/AMPK while increasing phosphorylated protein kinase B (pAKT)/AKT and mTORC1 activation; conditioned media from PDLLA-treated macrophages (CMPDLLA) restored pSTAT3/STAT3, DDIT4, and pAMPK/AMPK, reduced pAKT/AKT, and suppressed pmTOR/mTOR. CMPDLLA attenuated downstream inflammatory responses, including NF-κB nuclear translocation, VEGF production, and NLRP3-inflammasome-mediated IL-18 secretion. These findings were validated using an intradermal LL-37-injected mouse model. Compared with the normal control/saline group, LL-37/saline decreased IL-10, pSTAT3/STAT3, DDIT4, and pAMPK/AMPK while increasing pAKT/AKT, pmTOR/mTOR, pS6K/S6K, TLR2/KLK5/LL-37, NF-κB, VEGF, and NLRP3 inflammasome/IL-18 signaling; PDLLA partially restored the STAT3/DDIT4–AMPK regulatory pattern and suppressed these disease-associated signals. Consequently, PDLLA treatment led to a pronounced reduction in clinical lesion area. Overall, PDLLA may attenuate LL-37-driven cutaneous inflammation by promoting an IL-10-linked STAT3/DDIT4–AKT/AMPK program that suppresses mTORC1 and disrupts cathelicidin amplification, supporting its potential as an injectable immunomodulatory approach for rosacea-like skin inflammation.
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1) , 5615820
Effects of Nonthermal Electromagnetic Stimulation on Facial Skin Biophysical Parameters and Clinical Outcomes: A Prospective Pilot Study
Introduction: Nonthermal electromagnetic stimulation has been investigated for its potential effects on tissue repair, regeneration, and inflammatory modulation. However, clinical evidence regarding its use as a standalone modality for facial skin rejuvenation remains limited. This prospective pilot study evaluated the effects of nonthermal electromagnetic stimulation on facial skin biophysical parameters and clinical outcomes. Methods: In this prospective, single‐arm pilot study, 20 Korean adults with facial skin aging underwent five weekly sessions of electromagnetic stimulation using CoreSculpt‐F. Assessments were performed at baseline and follow‐up visits through Week 8. Objective outcomes included transepidermal water loss (TEWL), skin hydration, cutometer‐derived elasticity parameters (R2, R5, and R7), melanin and erythema indices, and imaging‐based analysis. Patient satisfaction, investigator global assessment, and adverse events were also evaluated. Results: Nineteen participants completed all treatment sessions and the Week 8 follow‐up visit. TEWL decreased significantly over time, indicating improved epidermal barrier function. Skin hydration showed a numerical increase without statistical significance. Skin elasticity parameters R2 and R7 increased significantly, whereas R5 did not change significantly. The erythema index decreased significantly, while the melanin index showed a modest but significant reduction. Imaging analysis demonstrated significant reductions in erythema and increased skin radiance. Patient satisfaction improved significantly with all subjects reporting satisfaction (score ≥ 4) at the final visit. Investigator assessments also showed significant improvement. No serious adverse events were observed. Conclusions: Nonthermal electromagnetic stimulation was associated with improvements in facial skin biophysical parameters, including barrier function, elasticity, and erythema‐related skin tone, along with favorable clinical outcomes. These preliminary findings suggest that nonthermal electromagnetic stimulation may represent a promising noninvasive approach for facial skin rejuvenation. Further randomized, sham‐controlled studies with larger sample sizes and longer follow‐up periods are warranted to confirm these results. Trial Registration: Clinical Research Information Service (CRIS): PRE20260522‐004
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1) , 5615820
Open AccessEffects of Nonthermal Electromagnetic Stimulation on Facial Skin Biophysical Parameters and Clinical Outcomes: A Prospective Pilot Study
Introduction: Nonthermal electromagnetic stimulation has been investigated for its potential effects on tissue repair, regeneration, and inflammatory modulation. However, clinical evidence regarding its use as a standalone modality for facial skin rejuvenation remains limited. This prospective pilot study evaluated the effects of nonthermal electromagnetic stimulation on facial skin biophysical parameters and clinical outcomes. Methods: In this prospective, single‐arm pilot study, 20 Korean adults with facial skin aging underwent five weekly sessions of electromagnetic stimulation using CoreSculpt‐F. Assessments were performed at baseline and follow‐up visits through Week 8. Objective outcomes included transepidermal water loss (TEWL), skin hydration, cutometer‐derived elasticity parameters (R2, R5, and R7), melanin and erythema indices, and imaging‐based analysis. Patient satisfaction, investigator global assessment, and adverse events were also evaluated. Results: Nineteen participants completed all treatment sessions and the Week 8 follow‐up visit. TEWL decreased significantly over time, indicating improved epidermal barrier function. Skin hydration showed a numerical increase without statistical significance. Skin elasticity parameters R2 and R7 increased significantly, whereas R5 did not change significantly. The erythema index decreased significantly, while the melanin index showed a modest but significant reduction. Imaging analysis demonstrated significant reductions in erythema and increased skin radiance. Patient satisfaction improved significantly with all subjects reporting satisfaction (score ≥ 4) at the final visit. Investigator assessments also showed significant improvement. No serious adverse events were observed. Conclusions: Nonthermal electromagnetic stimulation was associated with improvements in facial skin biophysical parameters, including barrier function, elasticity, and erythema‐related skin tone, along with favorable clinical outcomes. These preliminary findings suggest that nonthermal electromagnetic stimulation may represent a promising noninvasive approach for facial skin rejuvenation. Further randomized, sham‐controlled studies with larger sample sizes and longer follow‐up periods are warranted to confirm these results. Trial Registration: Clinical Research Information Service (CRIS): PRE20260522‐004
- Open Access
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Targeted Precision Cryotherapy With a Poly‐D,L‐Lactic Acid–Hyaluronic Acid Hybrid Filler for Facial Skin Quality Enhancement: A Controlled Study
Background: Targeted precision cryotherapy has emerged as a novel approach in aesthetic dermatology, offering enhanced precision and safety during procedures. This study evaluated the efficacy and safety of a poly‐D,L‐lactic acid–hyaluronic acid (PDLLA–HA) hybrid filler administered using a TargetCool device to improve facial skin quality. Materials and Methods: A prospective controlled study was conducted in 20 Korean women with melasma, hyperpigmentation, or dark spots. One hemiface was treated with PDLLA–HA using a precision cryotherapy device, while the contralateral side received the same formulation via a microneedle roller. Skin parameters, including melanin content, dermal density, pore volume, pore density, pore count, and redness, were assessed at baseline, during treatment, and 1 month after the final session. Visual grading, patient‐reported outcomes, and safety evaluations were also performed. Results: Cryotherapy‐assisted delivery demonstrated significantly greater improvements than microneedling in melanin reduction (31.28% vs. 23.40%), dermal density (30.07% vs. 17.37%), and pore‐related parameters, including volume (53.43% vs. 33.61%) and density (57.80% vs. 21.62%). Redness was significantly reduced on the cryotherapy‐treated side. Participant satisfaction was high, with consistent improvements in skin texture and overall appearance. No adverse events were observed. Conclusion: Precision cryotherapy‐assisted delivery of PDLLA + HA provides superior efficacy and favorable safety compared with conventional application methods. This approach may enhance transdermal delivery while minimizing tissue trauma, representing a promising strategy for advanced aesthetic dermatologic treatments.
- 1 January 2026
- Published by Wiley in Dermatologic Therapy
- Vol. 2026 (1)
Open AccessTargeted Precision Cryotherapy With a Poly‐D,L‐Lactic Acid–Hyaluronic Acid Hybrid Filler for Facial Skin Quality Enhancement: A Controlled Study
Background: Targeted precision cryotherapy has emerged as a novel approach in aesthetic dermatology, offering enhanced precision and safety during procedures. This study evaluated the efficacy and safety of a poly‐D,L‐lactic acid–hyaluronic acid (PDLLA–HA) hybrid filler administered using a TargetCool device to improve facial skin quality. Materials and Methods: A prospective controlled study was conducted in 20 Korean women with melasma, hyperpigmentation, or dark spots. One hemiface was treated with PDLLA–HA using a precision cryotherapy device, while the contralateral side received the same formulation via a microneedle roller. Skin parameters, including melanin content, dermal density, pore volume, pore density, pore count, and redness, were assessed at baseline, during treatment, and 1 month after the final session. Visual grading, patient‐reported outcomes, and safety evaluations were also performed. Results: Cryotherapy‐assisted delivery demonstrated significantly greater improvements than microneedling in melanin reduction (31.28% vs. 23.40%), dermal density (30.07% vs. 17.37%), and pore‐related parameters, including volume (53.43% vs. 33.61%) and density (57.80% vs. 21.62%). Redness was significantly reduced on the cryotherapy‐treated side. Participant satisfaction was high, with consistent improvements in skin texture and overall appearance. No adverse events were observed. Conclusion: Precision cryotherapy‐assisted delivery of PDLLA + HA provides superior efficacy and favorable safety compared with conventional application methods. This approach may enhance transdermal delivery while minimizing tissue trauma, representing a promising strategy for advanced aesthetic dermatologic treatments.
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (1) , 69-74
Assessing Laser Safety in Dermatology: Eye Protection and Infection Control Practices Among Board-Certified Korean Dermatologists
Oh S, et al. Ann Dermatol. 2025 Nov;38:e8. https://doi.org/10.5021/ad.25.112
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (1) , 69-74
Open AccessAssessing Laser Safety in Dermatology: Eye Protection and Infection Control Practices Among Board-Certified Korean Dermatologists
Oh S, et al. Ann Dermatol. 2025 Nov;38:e8. https://doi.org/10.5021/ad.25.112
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (1) , 42-50
Current Clinical Perspectives on Rosacea Management: Insights From a Korean Multicenter Expert Opinion Survey
Kim BR, et al. Ann Dermatol. 2025 Oct;38:e4. https://doi.org/10.5021/ad.25.130
- 1 January 2026
- Published by XMLink in Annals of Dermatology
- Vol. 38 (1) , 42-50
Open AccessCurrent Clinical Perspectives on Rosacea Management: Insights From a Korean Multicenter Expert Opinion Survey
Kim BR, et al. Ann Dermatol. 2025 Oct;38:e4. https://doi.org/10.5021/ad.25.130
- 13 December 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (9) , 3382-3388
The Effective Delivery of Poly(D,L-lactic Acid) (Juvelook) via Needle-Free Injection (CUREJET) for Facial Rejuvenation
Background Poly(D,L-lactic acid) (PDLLA) is increasingly used for skin rejuvenation, utilizing innovative delivery systems like needle-free injectors to enhance patient comfort and efficacy. Objective To evaluate the clinical efficacy and safety of PDLLA delivered through a microjet injector and to assess the durability of its rejuvenating effect over 24 weeks. Methods This study involved 40 patients who underwent five treatment sessions of PDLLA (Juvelook) treatment via a needle-free microjet system. Efficacy was assessed through clinical evaluation (GAIS), patient satisfaction surveys, and 3D imaging analysis at baseline, 8 weeks, and 24 weeks. Results GAIS scores improved from 1.48 ± 0.32 at baseline to 1.90 ± 0.28 at 8 weeks and 2.16 ± 0.26 at 24 weeks (p < 0.001). Patient satisfaction increased from 3.38 ± 1.12 to 7.95 ± 0.86 (8 weeks) and 8.71 ± 0.69 (24 weeks). 3D imaging showed progressive vector displacement, with a mean displacement of 1.5 ± 0.4 mm at 8 weeks and 2.3 ± 0.5 mm at 24 weeks, indicating sustained lifting and textural improvement. These effects are attributed to the high-velocity microjet delivery mechanism, which enables uniform intradermal dispersion with minimal trauma. Conclusion PDLLA (Juvelook) delivered via needle-free injection (CUREJET, BAZ BIOMEDIC CO., LTD.) is a safe and effective modality for facial rejuvenation, offering a promising alternative to conventional methods. Further research is needed to explore long-term outcomes and mechanistic insights. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 13 December 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (9) , 3382-3388
The Effective Delivery of Poly(D,L-lactic Acid) (Juvelook) via Needle-Free Injection (CUREJET) for Facial Rejuvenation
Background Poly(D,L-lactic acid) (PDLLA) is increasingly used for skin rejuvenation, utilizing innovative delivery systems like needle-free injectors to enhance patient comfort and efficacy. Objective To evaluate the clinical efficacy and safety of PDLLA delivered through a microjet injector and to assess the durability of its rejuvenating effect over 24 weeks. Methods This study involved 40 patients who underwent five treatment sessions of PDLLA (Juvelook) treatment via a needle-free microjet system. Efficacy was assessed through clinical evaluation (GAIS), patient satisfaction surveys, and 3D imaging analysis at baseline, 8 weeks, and 24 weeks. Results GAIS scores improved from 1.48 ± 0.32 at baseline to 1.90 ± 0.28 at 8 weeks and 2.16 ± 0.26 at 24 weeks (p < 0.001). Patient satisfaction increased from 3.38 ± 1.12 to 7.95 ± 0.86 (8 weeks) and 8.71 ± 0.69 (24 weeks). 3D imaging showed progressive vector displacement, with a mean displacement of 1.5 ± 0.4 mm at 8 weeks and 2.3 ± 0.5 mm at 24 weeks, indicating sustained lifting and textural improvement. These effects are attributed to the high-velocity microjet delivery mechanism, which enables uniform intradermal dispersion with minimal trauma. Conclusion PDLLA (Juvelook) delivered via needle-free injection (CUREJET, BAZ BIOMEDIC CO., LTD.) is a safe and effective modality for facial rejuvenation, offering a promising alternative to conventional methods. Further research is needed to explore long-term outcomes and mechanistic insights. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 27 October 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (3) , 1269-1276
Efficacy of Cryogenic Particle Delivery in Enhancing Skin Penetration and Absorption
Background Cryogenic particle delivery is a novel cryotherapy-based transdermal delivery system that converts liquid drugs into micro-ice-crystallised needles, which are propelled into the skin using a cryogenic CO2 jet. This study evaluates its efficacy in enhancing skin penetration and absorption, alone and in combination with the Microneedle Therapy System (MTS). Objective To assess fluorescence intensity, penetration depth, and structural integrity in ex vivo human skin tissues treated with cryogenic particle delivery, MTS, or a combination of both. Methods Ex vivo human skin tissues were divided into four groups: untreated (Control), MTS alone (Control 1), MTS combined with cryogenic particle delivery (Control 2), and Picolitre ice particle delivery alone (Test Group). Fluorescence-labelled hyaluronic acid (HA-FITC) was applied, and fluorescence intensity and penetration depth were evaluated using confocal microscopy. Structural integrity was assessed through haematoxylin and eosin (H&E) staining. Statistical analysis was performed using paired t tests (p < 0.05). Results Fluorescence intensity increased significantly in all treated groups compared to the untreated control: by 279.06 (MTS alone), 492.81 (MTS + cryogenic particle delivery), and 251.88% (cryogenic particle delivery alone) (p < 0.05). Penetration depth also increased significantly: by 52.00 (MTS alone), 60.06 (MTS + cryogenic particle delivery), and 36.99% (Cryogenic particle delivery alone). H&E staining confirmed no structural damage in any group. Conclusion Cryogenic particle delivery significantly enhances skin penetration and absorption, particularly when combined with MTS, demonstrating a synergistic effect. Its ability to deliver compounds safely and effectively highlights its potential as a transformative tool for therapeutic and cosmetic transdermal applications. Future in vivo studies are warranted to validate these findings and optimise its clinical applications. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 27 October 2025
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 50 (3) , 1269-1276
Efficacy of Cryogenic Particle Delivery in Enhancing Skin Penetration and Absorption
Background Cryogenic particle delivery is a novel cryotherapy-based transdermal delivery system that converts liquid drugs into micro-ice-crystallised needles, which are propelled into the skin using a cryogenic CO2 jet. This study evaluates its efficacy in enhancing skin penetration and absorption, alone and in combination with the Microneedle Therapy System (MTS). Objective To assess fluorescence intensity, penetration depth, and structural integrity in ex vivo human skin tissues treated with cryogenic particle delivery, MTS, or a combination of both. Methods Ex vivo human skin tissues were divided into four groups: untreated (Control), MTS alone (Control 1), MTS combined with cryogenic particle delivery (Control 2), and Picolitre ice particle delivery alone (Test Group). Fluorescence-labelled hyaluronic acid (HA-FITC) was applied, and fluorescence intensity and penetration depth were evaluated using confocal microscopy. Structural integrity was assessed through haematoxylin and eosin (H&E) staining. Statistical analysis was performed using paired t tests (p < 0.05). Results Fluorescence intensity increased significantly in all treated groups compared to the untreated control: by 279.06 (MTS alone), 492.81 (MTS + cryogenic particle delivery), and 251.88% (cryogenic particle delivery alone) (p < 0.05). Penetration depth also increased significantly: by 52.00 (MTS alone), 60.06 (MTS + cryogenic particle delivery), and 36.99% (Cryogenic particle delivery alone). H&E staining confirmed no structural damage in any group. Conclusion Cryogenic particle delivery significantly enhances skin penetration and absorption, particularly when combined with MTS, demonstrating a synergistic effect. Its ability to deliver compounds safely and effectively highlights its potential as a transformative tool for therapeutic and cosmetic transdermal applications. Future in vivo studies are warranted to validate these findings and optimise its clinical applications. Level of Evidence V This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Dermatology
- Vol. 37 (3) , 123-130
Real-World Clinical Practice on Skin Rejuvenation Among Korean Board-Certified Dermatologists: Survey-Based Results
Oh S, et al. Ann Dermatol. 2025 Jun;37(3):123-130. https://doi.org/10.5021/ad.24.167
- 1 January 2025
- Published by XMLink in Annals of Dermatology
- Vol. 37 (3) , 123-130
Open AccessReal-World Clinical Practice on Skin Rejuvenation Among Korean Board-Certified Dermatologists: Survey-Based Results
Oh S, et al. Ann Dermatol. 2025 Jun;37(3):123-130. https://doi.org/10.5021/ad.24.167
- Open Access
- 27 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (23) , 12739
Poly-D,L-Lactic Acid Fillers Increase Subcutaneous Adipose Tissue Volume by Promoting Adipogenesis in Aged Animal Skin
During aging, subcutaneous white adipose tissue (sWAT) thickness and the adipogenic potential of adipose-derived stem cells (ASCs) decline. Poly-D,L-lactic acid (PDLLA) fillers are commonly used to restore diminished facial volume. Piezo1 increases polarizing macrophages towards the M2 phenotype, which promotes the secretion of fibroblast growth factor 2 (FGF2), thereby increasing ASC survival. This study evaluated whether PDLLA enhances adipogenesis in ASCs by modulating M2 polarization in an in vitro senescence model and in aged animals. Lipopolysaccharide (LPS)-induced senescent macrophages showed decreased Piezo1, which was upregulated by PDLLA. CD163 (an M2 marker) and FGF2 were downregulated in senescent macrophages but were upregulated by PDLLA. We evaluated whether reduced FGF2 secretion from senescent macrophages affects ASCs by applying conditioned media (CM) from macrophage cultures to ASCs. CM from senescent macrophages decreased ERK1/2 and proliferation in ASCs, both of which were restored by CM from PDLLA-stimulated senescent macrophages. Adipogenesis inducers (PPAR-γ and C/EBP-α) were downregulated by CM from senescent macrophages but upregulated by CM from PDLLA-stimulated senescent macrophages in ASCs. Similar patterns were observed in aged animal adipose tissue. PDLLA increased Piezo1 activity, M2 polarization, and FGF2 levels. PDLLA also enhanced ERK1/2, cell proliferation, PPAR-γ, and C/EBP-α expression, leading to increased adipose tissue thickness. In conclusion, our study showed that PDLLA increased adipose tissue thickness by modulating adipogenesis.
- 27 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (23) , 12739
Open AccessPoly-D,L-Lactic Acid Fillers Increase Subcutaneous Adipose Tissue Volume by Promoting Adipogenesis in Aged Animal Skin
During aging, subcutaneous white adipose tissue (sWAT) thickness and the adipogenic potential of adipose-derived stem cells (ASCs) decline. Poly-D,L-lactic acid (PDLLA) fillers are commonly used to restore diminished facial volume. Piezo1 increases polarizing macrophages towards the M2 phenotype, which promotes the secretion of fibroblast growth factor 2 (FGF2), thereby increasing ASC survival. This study evaluated whether PDLLA enhances adipogenesis in ASCs by modulating M2 polarization in an in vitro senescence model and in aged animals. Lipopolysaccharide (LPS)-induced senescent macrophages showed decreased Piezo1, which was upregulated by PDLLA. CD163 (an M2 marker) and FGF2 were downregulated in senescent macrophages but were upregulated by PDLLA. We evaluated whether reduced FGF2 secretion from senescent macrophages affects ASCs by applying conditioned media (CM) from macrophage cultures to ASCs. CM from senescent macrophages decreased ERK1/2 and proliferation in ASCs, both of which were restored by CM from PDLLA-stimulated senescent macrophages. Adipogenesis inducers (PPAR-γ and C/EBP-α) were downregulated by CM from senescent macrophages but upregulated by CM from PDLLA-stimulated senescent macrophages in ASCs. Similar patterns were observed in aged animal adipose tissue. PDLLA increased Piezo1 activity, M2 polarization, and FGF2 levels. PDLLA also enhanced ERK1/2, cell proliferation, PPAR-γ, and C/EBP-α expression, leading to increased adipose tissue thickness. In conclusion, our study showed that PDLLA increased adipose tissue thickness by modulating adipogenesis.